Drupal.behaviors.print = function(context) {window.print();window.close();}>
Meridian Bioscience Reports 13 Percent Spike in Q1 Revenues Driven by Growth in Illumigene Products
January 24, 2013
Meridian Bioscience Reports 13 Percent Spike in Q1 Revenues Driven by Growth in Illumigene Products
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Meridian Bioscience NAAT for Group A Strep Shines in Multicenter Clinical Study
March 7, 2013 / PCR Insider
Meridian Biosciences Views Universal Sample Prep Method as Enabler of Future MDx Tests
December 20, 2012 / PCR Insider
Dx Focus: FDA Approves Meridian Bioscience Group B Strep Test; Hologic Cervista HTA System
December 15, 2011 / PCR Insider
Dx Focus: Meridian's Illumigene Group A, B Strep Tests; Cynvenio Biosystems' LiquidBiopsy Service
March 21, 2013 / PCR Insider
FDA Recategorizes Meridian's Molecular Strep A and B Assays as 'Moderate Complexity' Tests
March 19, 2013 / GenomeWeb Daily News